Table 1.
The General Data of the Trial and Control Group
| Item | Trial group (n = 69) | Control group (n = 36) | P | |
| Sex | 0.362 | |||
| Male | 50 | 29 | ||
| Female | 19 | 7 | ||
| Median age (year) | 52 | 51 | 0.437 | |
| Type of tumors | 0.638* | |||
| NSCLC | 17 | 6 | ||
| Gastric cancer | 32 | 18 | ||
| Colorectal cancer | 20 | 12 | ||
| KPS ( |
85.31 ± 6.07 | 86.69 ± 7.81 | 0.334 | |
| Clinical stage | 0.630 | |||
| III | 11 | 8 | ||
| IV | 58 | 28 | ||
| NSCLC | III | 5 | 3 | 0.621* |
| IV | 12 | 3 | ||
| Gastric cancer | III | 4 | 3 | 0.684 |
| IV | 28 | 15 | ||
| Colorectal cancer | III | 2 | 2 | 0.620* |
| IV | 18 | 10 |
*The p value is calculated by Fisher exact chi-square because n < 30 or some cells have expected count less than 1.